CM
JAZZ icon

Caption Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Caption Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-50,300
Closed -$7.17M – 1115
2020
Q3 		$7.17M Sell
50,300
-44,700
-47% -$5.54M 0.17% 142
2020
Q2 		$10.5M Buy
+95,000
New +$10.5M 0.35% 51

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Caption Management's JAZZ Position: Q1 2026 in Review

Caption Management sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2026, closing a stake of 10,747 shares — an estimated $1.88M sold.

Caption Management first reported a position in JAZZ in Q2 2020 and held it in 6 quarters. The position peaked at $10.8M in Q1 2021. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Caption Management reported no remaining Jazz Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Caption Management sold 10,747 Jazz Pharmaceuticals shares in Q1 2026, an estimated $1.88M.
  • Caption Management first reported a position in Jazz Pharmaceuticals in Q2 2020 and held it in 6 quarters.
  • Caption Management's Jazz Pharmaceuticals position peaked at $10.8M in Q1 2021.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.